Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Non-Current Debt (2021 - 2025)

Historic Non-Current Debt for Ascendis Pharma A (ASND) over the last 5 years, with Q4 2025 value amounting to $448.5 million.

  • Ascendis Pharma A's Non-Current Debt rose 1496.21% to $448.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $448.5 million, marking a year-over-year increase of 1496.21%. This contributed to the annual value of $435.4 million for FY2025, which is 1159.98% up from last year.
  • Ascendis Pharma A's Non-Current Debt amounted to $448.5 million in Q4 2025, which was up 1496.21% from $498.3 million recorded in Q3 2025.
  • Ascendis Pharma A's Non-Current Debt's 5-year high stood at $598.2 million during Q3 2023, with a 5-year trough of $112.1 million in Q4 2021.
  • In the last 5 years, Ascendis Pharma A's Non-Current Debt had a median value of $472.9 million in 2025 and averaged $461.5 million.
  • In the last 5 years, Ascendis Pharma A's Non-Current Debt surged by 25281.7% in 2022 and then tumbled by 2250.95% in 2024.
  • Ascendis Pharma A's Non-Current Debt (Quarter) stood at $112.1 million in 2021, then surged by 252.82% to $395.4 million in 2022, then rose by 10.78% to $438.0 million in 2023, then decreased by 10.93% to $390.1 million in 2024, then increased by 14.96% to $448.5 million in 2025.
  • Its Non-Current Debt stands at $448.5 million for Q4 2025, versus $498.3 million for Q3 2025 and $473.2 million for Q2 2025.